Filing Details

Accession Number:
0001209191-18-036135
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-06 17:50:50
Reporting Period:
2018-06-04
Accepted Time:
2018-06-06 17:50:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574700 Carol Moore C/O Cerus Corporation
2550 Stanwell Drive
Concord CA 94520
Svp Reg. & Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-04 5,522 $0.79 46,363 No 4 M Direct
Common Stock Disposition 2018-06-04 5,522 $6.70 40,841 No 4 S Direct
Common Stock Acquisiton 2018-06-05 69,478 $0.79 110,319 No 4 M Direct
Common Stock Disposition 2018-06-05 69,478 $6.72 40,841 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2018-06-04 5,522 $0.00 5,522 $0.79
Common Stock Option (Right to Buy) Disposition 2018-06-05 69,478 $0.00 69,478 $0.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
69,478 2019-01-11 No 4 M Direct
0 2019-01-11 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $6.70 to $6.76. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter.
  3. Not applicable.